Atlas Trials

Administration of MELPIDA to Determine the Safety and Efficacy for Patients With Spastic Paraplegia Type 50

Clinical trial NCT06069687 · ACTIVE_NOT_RECRUITING

Trial details

NCT number
NCT06069687
Sponsor
The Hospital for Sick Children
Status
ACTIVE_NOT_RECRUITING
Phase
Phase 1
Study type
INTERVENTIONAL
Spastic Paraplegia Type 50
Start date
2022-03-11
Primary completion
2027-03-01
Enrollment
1

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.